← Open Payments lookup

JULIE HEEB: Open Payments

NPI 1093101958 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,214 in 56 payments from 10 companies in 2025. Trend: 2023 $399 · 2024 $738 · 2025 $1,214

Food & beverage: $1,214
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.10$338
Alkermes, Inc.11$204
Lundbeck LLC7$142
E.R. Squibb & Sons, L.L.C.8$137
Otsuka America Pharmaceutical, Inc.5$86
Vanda Pharmaceuticals Inc.4$77
Neurocrine BioSciences, Inc.3$73
Janssen Pharmaceuticals, Inc4$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$53
ABBVIE INC.2$36

Products named: UZEDY, ARISTADA, ABILIFY ASIMTUFII, COBENFY, REXULTI, FANAPT, INGREZZA, INVEGA SUSTENNA.

Industry payments across MO — which companies pay providers there.